CIM
BPMC

CIM Investment Management’s Blueprint Medicines BPMC Stock Holding History

CIM Investment Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,825
Closed -$290K – 303
2021
Q3 		$290K Hold
2,825
– – 0.09% 207
2021
Q2 		$248K Hold
2,825
– – 0.08% 248
2021
Q1 		$275K Sell
2,825
-169
-6% -$16.9K 0.09% 220
2020
Q4 		$336K Hold
2,994
– – 0.11% 193
2020
Q3 		$278K Buy
2,994
+44
+1% +$3.39K 0.11% 180
2020
Q2 		$230K Sell
2,950
-2,123
-42% -$144K 0.09% 208
2020
Q1 		$297K Sell
5,073
-73
-1% -$4.7K 0.15% 133
2019
Q4 		$412K Sell
5,146
-800
-13% -$59.9K 0.16% 132
2019
Q3 		$437K Buy
+5,946
New +$514K 0.16% 149
2019
Q2 		– Sell
-3,105
Closed -$249K – 318
2019
Q1 		$249K Sell
3,105
-3,165
-50% -$234K 0.1% 274
2018
Q4 		$338K Hold
6,270
– – 0.15% 183
2018
Q3 		$489K Buy
6,270
+2,839
+83% +$197K 0.17% 160
2018
Q2 		$218K Hold
3,431
– – 0.08% 321
2018
Q1 		$315K Buy
+3,431
New +$296K 0.11% 255

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIM Investment Management's BPMC Position: Q4 2021 in Review

CIM Investment Management sold out of Blueprint Medicines (BPMC) in Q4 2021, closing a stake of 2,825 shares — an estimated $290K sold.

CIM Investment Management first reported a position in BPMC in Q1 2018 and held it in 14 quarters. The position peaked at $489K in Q3 2018. 280 funds tracked by Wall St. Rank hold BPMC as of Q4 2021.

  • CIM Investment Management reported no remaining Blueprint Medicines position as of Q4 2021 after selling out during the quarter.
  • CIM Investment Management sold 2,825 Blueprint Medicines shares in Q4 2021, an estimated $290K.
  • CIM Investment Management first reported a position in Blueprint Medicines in Q1 2018 and held it in 14 quarters.
  • CIM Investment Management's Blueprint Medicines position peaked at $489K in Q3 2018.
  • 280 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2021.

Based on CIM Investment Management's 13F filing for Q4 2021, filed 2 Feb 2022.